Detalhe da pesquisa
1.
GPRC5D-Targeted CAR T Cells for Myeloma.
N Engl J Med
; 387(13): 1196-1206, 2022 09 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-36170501
2.
How I treat unique and difficult-to-manage cases of CAR T-cell therapy-associated neurotoxicity.
Blood
; 141(20): 2443-2451, 2023 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36877916
3.
Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(4): 387-405, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390769
4.
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.
N Engl J Med
; 378(5): 449-459, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29385376
5.
Progressive multifocal leukoencephalopathy in patients treated with chimeric antigen receptor T cells.
Blood
; 141(6): 673-677, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332168
6.
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020.
J Natl Compr Canc Netw
; 18(3): 230-241, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32135517
7.
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells.
Biol Blood Marrow Transplant
; 25(4): 625-638, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30592986
8.
Management of Immunotherapy-Related Toxicities, Version 1.2019.
J Natl Compr Canc Netw
; 17(3): 255-289, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30865922
9.
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma.
Haematologica
; 106(1): 255-258, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079691
10.
T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation.
Eur J Immunol
; 44(11): 3240-51, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25103845
11.
12.
Immune Checkpoint Inhibitor-Associated Optic Neuritis.
Ophthalmology
; 127(11): 1585-1589, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32437864
13.
Reply.
Biol Blood Marrow Transplant
; 25(6): e211-e212, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30910604
14.
CD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results.
Nat Med
; 29(7): 1710-1717, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37400640
15.
Multifocal and pathologically-confirmed brain metastasis complete response to trastuzumab deruxtecan.
CNS Oncol
; 11(3): CNS90, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35674041
16.
Incidence and management of CAR-T neurotoxicity in patients with multiple myeloma treated with ciltacabtagene autoleucel in CARTITUDE studies.
Blood Cancer J
; 12(2): 32, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35210399
17.
Toward a Better Understanding of the Atypical Features of Chronic Graft-Versus-Host Disease: A Report from the 2020 National Institutes of Health Consensus Project Task Force.
Transplant Cell Ther
; 28(8): 426-445, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35662591
18.
Neurotoxicity Biology and Management.
Cancer J
; 27(2): 126-133, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33750072
19.
Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients.
Cancer Cell
; 39(2): 276-283.e3, 2021 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33508216
20.
Beyond Steroids: Immunosuppressants in Steroid-Refractory or Resistant Immune-Related Adverse Events.
J Thorac Oncol
; 16(10): 1759-1764, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34265432